Nomura Asset Management International »

Allogene Therapeutics shares owned by Nomura Asset Management International

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Nomura Asset Management International from 13F filings

Historical chart of Nomura Asset Management International investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Nomura Asset Management International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Nomura Asset Management International

Quarter filed Position value Share count Share price at filing
2026-03-31 $358k 147k 2.44

More positions owned by Nomura Asset Management International

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Seagate Technology Hldngs Pl Ord Shs (STX)
Howmet Aerospace (HWM)
Advanced Micro Devices (AMD)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Netflix (NFLX)
Mastercard Incorporated Cl A (MA)

View all positions for Nomura Asset Management International

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
State Street Corporation
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Marshall Wace
Millennium Management

View all funds holding Allogene Therapeutics